How Is Retinoblastoma Staged?

The stage of cancer describes how far it has spread. The outlook (prognosis) for children with retinoblastoma depends, to some extent, on the cancer’s stage. The stage is also an important factor in choosing treatment.

Retinoblastoma is staged based on the results of eye exams, imaging tests, and any biopsies that were done. These tests are described in “How is retinoblastoma diagnosed?

A staging system is a standard way for your child’s cancer care team to sum up how far a cancer has spread. Doctors use staging systems to predict the outlook for saving the child’s vision, as well as for survival and the likelihood that certain treatments will be effective.

Several detailed systems can be used to stage retinoblastoma (see below). But for practical purposes, when determining the best treatment options, doctors often divide retinoblastomas into 2 main groups:

  • Intraocular retinoblastoma: The cancer is still within the eye.
  • Extraocular retinoblastoma: The cancer has spread beyond the eye. Extraocular cancers can be divided further into orbital retinoblastomas, which have spread only to the eye socket, and metastatic retinoblastomas, which have spread to distant parts of the body, such as the brain or bone marrow.

In the United States, most retinoblastomas are diagnosed before they have spread outside the eye, so staging systems that apply only to intraocular retinoblastoma are used most often in this country. There are 2 staging systems for intraocular retinoblastomas.

It’s important to know that regardless of the stage, almost all children with intraocular retinoblastoma can be cured if they are properly treated. But the stage has a bigger impact on whether the affected eye (or the vision in the eye) can be saved.

International Classification for Intraocular Retinoblastoma

The International Classification for Intraocular Retinoblastoma is the newer staging system, which takes into account what has been learned about the disease in recent decades. Most doctors now use this system. It divides intraocular retinoblastomas into 5 groups, labeled A through E, based on the chances that the eye can be saved using current treatment options.

Group A

Small tumors (3 millimeters [mm] across or less) that are only in the retina and are not near important structures such as the optic disc (where the optic nerve enters the retina) or the foveola (the center of vision).

Group B

All other tumors (either larger than 3 mm or small but close to the optic disc or foveola) that are still only in the retina.

Group C

Well-defined tumors with small amounts of spread under the retina (subretinal seeding) or into the jelly-like material that fills the eye (vitreous seeding).

Group D

Large or poorly defined tumors with widespread vitreous or subretinal seeding. The retina may have become detached from the back of the eye.

Group E

The tumor is very large, extends near the front of the eye, is bleeding or causing glaucoma (high pressure inside the eye), or has other features that mean there is almost no chance the eye can be saved.

The Reese-Ellsworth staging system

The Reese-Ellsworth system was developed in the 1960s, when most children were being treated with external beam radiation therapy (EBRT). While this is no longer a common treatment, some doctors may still use this system to classify retinoblastomas that have not spread beyond the eye. This system can help determine the likelihood of preserving vision while still treating the tumor.

Terms such as favorable, doubtful, and unfavorable used in this staging system refer to the likelihood that the cancer can be treated while preserving the affected eye. These terms do not refer to the likelihood of the child’s survival. Indeed, more than 9 in 10 children with intraocular retinoblastomas are cured. The major challenge is saving the vision in the affected eye.

To explain the groupings below, it helps to define a few terms. The optic disc is the end of the optic nerve where it is attached to the retina. Retinoblastomas are diagnosed by looking at the retina through an ophthalmoscope, so doctors can’t measure their size directly using a ruler. Instead they compare the size of the tumor with the size of the optic disc, which is usually about 1.5 millimeters (1/16 inch) across. For example, a tumor estimated to be 3 times the size of the disc (3 disc diameters or 3 DD) would be about 4.5 millimeters (3/16 inch) across.

The equator is an imaginary line that divides the front and back halves of the eyeball.

The Reese-Ellsworth staging system divides intraocular retinoblastoma into 5 groups. The higher the group number, from 1 to 5, the lower the chance of controlling the retinoblastoma or of saving the eye or any useful vision.

Group 1 (very favorable for saving [or preserving] the eye)

  • 1A: one tumor, smaller than 4 disc diameters (DD), at or behind the equator
  • 1B: multiple tumors smaller than 4 DD, all at or behind the equator

Group 2 (favorable for saving [or preserving] the eye)

  • 2A: one tumor, 4 to 10 DD, at or behind the equator
  • 2B: multiple tumors, with at least one 4 to 10 DD, and all at or behind the equator

Group 3 (doubtful for saving [or preserving] the eye)

  • 3A: any tumor in front of the equator
  • 3B: one tumor, larger than 10 DD, behind the equator

Group 4 (unfavorable for saving [or preserving] the eye)

  • 4A: multiple tumors, some larger than 10 DD
  • 4B: any tumor extending toward the front of the eye to the ora serrata (front edge of the retina)

Group 5 (very unfavorable for saving [or preserving] the eye)

  • 5A: tumors involving more than half of the retina
  • 5B: vitreous seeding (spread of tumors into the jelly-like material that fills the eye)

Other staging systems

Other staging systems that include both intraocular retinoblastomas and those that have spread beyond the eye (extraocular retinoblastomas) may be used by some doctors. These can be especially useful in countries where these cancers are more likely to have spread by the time they are found. For example, the American Joint Commission on Cancer (AJCC) staging system takes into account 3 key pieces of information:

  • T: The size of the main (primary) tumor and how far it has grown within and outside of the eye
  • N: Whether or not the cancer has reached the lymph nodes (small, bean shaped collections of immune cells, to which cancers sometimes spread)
  • M: Whether or not the cancer has spread (metastasized) to distant parts of the body, such as the bone marrow, brain, skull, or long bones

This system can be used to describe the extent of retinoblastomas in detail, particularly for those that have spread outside the eye, which rarely happens in the United States.

Be sure to ask your child’s doctor if you have any questions about the stage of your child’s cancer.

The American Cancer Society medical and editorial content team
Our team is made up of doctors and master’s-prepared nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

Last Medical Review: March 12, 2015 Last Revised: March 12, 2015

American Cancer Society medical information is copyrighted material. For reprint requests, please contact